Amlodipine News
Court Grants Mylan's Motion To Dismiss '909 Patent In Amlodipine Besylate Suit With Pfizer
Mylan Laboratories Inc. reported that the U.S. Court granted its motion to dismiss the '909 patent from the patent infringement litigation between Pfizer and Mylan concerning Amlodipine Besylate Tablets.
A Case of Amlodipine Overdose
A case of severe amlodipine overdose with only mild symptoms is described.
Trial shows new hypertension hope
One of the largest clinical trials ever conducted has found that the rate of strokes and heart attacks can be cut in half when new blood pressure pill combinations are used.
Population pharmacokinetics of amlodipine in hypertensive children and adolescents
A population pharmacokinetic study was conducted in 74 hypertensive children (mean age 10.4 +/- 4.4 years [mean +/- SD]) receiving amlodipine (mean dose 0.17 +/- 0.13 mg/kg/d) chronically.
FDA approves new Lotrel (amlodipine besylate/benazepril hcl) dosage strengths lotrel now provides more flexible dosing for managing high blood pressure
Novartis Pharmaceuticals Corporation announced it has received marketing approval from the U.S. Food and Drug Administration (FDA) for two new dosing strengths of Lotrel (R) (amlodipine besylate/benazepril HCl), 5/40 mg and 10/40...